The effect of valsartan, captopril, or both on atherosclerotic events after myocardial infarction: An analysis of the VALIANT trial
Publication
, Conference
McMurray, JJV; Solomon, SD; Reed, SD; Velazquez, EJ; White, H; Howlett, JG; Maggioni, AP; Kober, L
Published in: JOURNAL OF CARDIAC FAILURE
August 1, 2005
Duke Scholars
Published In
JOURNAL OF CARDIAC FAILURE
ISSN
1071-9164
Publication Date
August 1, 2005
Volume
11
Issue
6
Start / End Page
S156 / S156
Location
Boca Raton, FL
Publisher
CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
Conference Name
9th Annual Scientific Meeting of the Heart-Failure-Society-of-America
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1110 Nursing
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
McMurray, J. J. V., Solomon, S. D., Reed, S. D., Velazquez, E. J., White, H., Howlett, J. G., … Kober, L. (2005). The effect of valsartan, captopril, or both on atherosclerotic events after myocardial infarction: An analysis of the VALIANT trial. In JOURNAL OF CARDIAC FAILURE (Vol. 11, pp. S156–S156). Boca Raton, FL: CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS.
McMurray, J. J. V., S. D. Solomon, S. D. Reed, E. J. Velazquez, H. White, J. G. Howlett, A. P. Maggioni, and L. Kober. “The effect of valsartan, captopril, or both on atherosclerotic events after myocardial infarction: An analysis of the VALIANT trial.” In JOURNAL OF CARDIAC FAILURE, 11:S156–S156. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS, 2005.
McMurray JJV, Solomon SD, Reed SD, Velazquez EJ, White H, Howlett JG, et al. The effect of valsartan, captopril, or both on atherosclerotic events after myocardial infarction: An analysis of the VALIANT trial. In: JOURNAL OF CARDIAC FAILURE. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS; 2005. p. S156–S156.
McMurray, J. J. V., et al. “The effect of valsartan, captopril, or both on atherosclerotic events after myocardial infarction: An analysis of the VALIANT trial.” JOURNAL OF CARDIAC FAILURE, vol. 11, no. 6, CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS, 2005, pp. S156–S156.
McMurray JJV, Solomon SD, Reed SD, Velazquez EJ, White H, Howlett JG, Maggioni AP, Kober L. The effect of valsartan, captopril, or both on atherosclerotic events after myocardial infarction: An analysis of the VALIANT trial. JOURNAL OF CARDIAC FAILURE. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS; 2005. p. S156–S156.
Published In
JOURNAL OF CARDIAC FAILURE
ISSN
1071-9164
Publication Date
August 1, 2005
Volume
11
Issue
6
Start / End Page
S156 / S156
Location
Boca Raton, FL
Publisher
CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
Conference Name
9th Annual Scientific Meeting of the Heart-Failure-Society-of-America
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1110 Nursing
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology